Lyodura use and the risk of iatrogenic Creutzfeldt-Jacob disease in Australia

Medical Journal of Australia

Volumn 180, Issue 4, 2004, Pages 177-181

  Brooke, Fiona J ^a   Boyd, Alison ^b   Klug, Genevieve M ^b   Masters, Colin L ^b   Collins, Steven J ^b  

^a Department of Health/Ageing ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LYODURA;

ARTICLE; AUSTRALIA; BRAIN SPONGIOSIS; CADAVER; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DURA MATER; EPIDEMIC; HEALTH CARE; HEALTH SURVEY; HUMAN; IATROGENIC DISEASE; JAPAN; RISK ASSESSMENT;

EID: 1342326615     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05863.x     Document Type: Article

References (24)

1. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-1081.
2. Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 1987; 36: 324-325.
3. Food and Drug Administration. FDA safety alert: possibly contaminated dura mater transplant material. Rockville, Md: US Department of Health and Human Services, Public Health Service, Apr 28 1987.
4. Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR Morb Mortal wkly Rep 1989; 38: 37-38.
5. Nakamura Y, Watanabe M, Nagoshi K, et al. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, 1979-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 1179-1181.
6. Hannah EL, Belay ED, Gambetti P, et al. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001; 56: 1080-1083.
7. Defebvre L, Destee A, Caron J, et al. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent. Neurology 1997; 48: 1470-1471.
8. Dobbins JG, Belay ED, Malecki J, et al. Creutzfeldt-Jakob disease in a recipient of a dura mater graft processed in the US: cause or coincidence? Neuroepidemiology 2000; 19: 62-66.
9. Nakamura Y, Aso E, Yanagawa H. Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 1999; 53: 218-220.
10. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep 1997; 46: 1066-1069.
11. Hoshi K, Yoshino H, Urata J, et al. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 2000; 55: 718-721.
12. Hamada C, Sadaike T, Fukushima M. Projection of Creutzfeldt-Jakob Disease frequency based on cadaveric dura transplantation in Japan. Neuroepidemiology 2003; 22: 57-64.
13. Boyd A, Fletcher A, Lee JS, et al. Transmissible spongiform encephalopathies in Australia. Commun Dis Intell 2001; 25: 248-252.
14. Collins S, Boyd A, Lee JS, et al. Creutzfeldt-Jakob disease in Australia 1970-1999. Neurology 2002; 59: 1365-1371.
15. Simpson D, Masters CL, Ohlrich G, et al. Iatrogenic Creutzfeldt-Jakob disease and its neurosurgical implications. J Clin Neurosci 1996; 3: 118-123.
16. Newcombe RL. Neurosurgery and iatrogenic transmission of Creutzfeldt-Jakob disease. Med J Aust 1996; 164: 603-604.
17. Huillard d'Aignaux J, Costagliola D, et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53: 1197-1201.
18. Brandel J-P, Preece M, Brown P, et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 2003; 362: 128-130.
19. Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J. CJD discrepancy. Nature 1991; 353: 801-802.
20. Antoine JC, Michel D, Bertholon P, et al. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 1997; 48: 1451-1453.
21. Dickinson AG, Fraser H, Outram GW. Scrapie incubation time can exceed natural lifespan. Nature 1975; 256: 732-733.
22. Hill AF, Joiner S, Linehan J, et al. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 2000; 97: 10248-10253.
23. Frigg R, Klein MA, Hegyi I, et al. Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J Virol 1999; 73: 9584-9588.
24. Race R, Chesebro B. Scrapie infectivity found in resistant species. Nature 1998; 392: 770.